REGENXBIO’s $1.8 Billion Partnership With AbbVie

Martina Bellini
Tagged:

McDermott Will & Emery represented REGENXBIO in the transaction.REGENXBIO closed its $1.8 billion strategic partnership with AbbVie to develop and commercialize RGX-314, a potential one-time gene…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now